{"id":"NCT05285644","sponsor":"Aerie Pharmaceuticals","briefTitle":"Study Evaluating the Safety and Efficacy of AR-15512","officialTitle":"A Phase 3 Study Evaluating the Safety and Efficacy of AR-15512, a Cold Thermoreceptor Modulator, for the Treatment of Dry Eye Disease (COMET-2)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-05-09","primaryCompletion":"2023-07-24","completion":"2023-07-24","firstPosted":"2022-03-17","resultsPosted":"2025-07-23","lastUpdate":"2025-07-23"},"enrollment":465,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Dry Eye Disease"],"interventions":[{"type":"DRUG","name":"0.003% AR-15512 ophthalmic solution","otherNames":[]},{"type":"DRUG","name":"AR-15512 vehicle ophthalmic solution","otherNames":[]}],"arms":[{"label":"0.003% AR-15512","type":"EXPERIMENTAL"},{"label":"AR-15512 Vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"This will be a Phase 3, multicenter, vehicle-controlled, double-masked, randomized study conducted at approximately 20 sites in the United States. All subjects enrolled will have dry eye disease (DED). The study will consist of Screening (Day -14) and Baseline (Day 1) visits as well as visits at Day 7, Day 14, Day 28, and Day 90 (Study Exit) for an individual duration of participation of approximately 15 weeks.","primaryOutcome":{"measure":"Percentage of Subjects Who Achieved Equal to or Greater Than 10 Millimeter Increase From Pre-drop at Baseline to Post-drop on Day 14 in Study Eye Unanesthetized Schirmer Score","timeFrame":"Baseline (Day 1) pre-drop; Day 14 post-drop","effectByArm":[{"arm":"0.003% AR-15512","deltaMin":42.6,"sd":null},{"arm":"AR-15512 Vehicle","deltaMin":8.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"30 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":6},"locations":{"siteCount":23,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":465},"commonTop":["Instillation site pain"]}}